A recent study from Turkey appears to confirm earlier reports that olive leaf extract could be beneficial for the prevention and treatment of Type 2 diabetes.
A study led by professor Abdurrahim Koçyiğit suggested that olive leaf extract could help treat Type 2 diabetes by improving insulin sensitivity and activity, as well as pancreatic responsiveness. However, professor Roy Taylor from Newcastle University’s diabetes research center expressed skepticism, stating that the study’s findings were not supportive of a role in treatment or prevention of Type 2 diabetes due to normal insulin receptor function in the disease.
A study published in the American Journal of Plant Sciences suggested that olive leaf extract could play a role in treating Type 2 diabetes by helping to balance blood sugar.
The study was led by professor Abdurrahim Koçyiğit from Istanbul’s Fatih Sultan Mehmet University who told the Daily Sabah newspaper that the main issue with Type 2 diabetes was insulin resistance.
The study is merely a report of alteration in insulin receptor activity in the test tube. As insulin receptor function is normal in Type 2 diabetes (despite much confusing information) this is not supportive of a role in treatment or prevention.- Roy Taylor, professor at the Newcastle University the diabetes research center
According to Koçyiğit, although sufferers of Type 2 diabetes generally have higher than normal insulin levels most of the time, they also display high blood sugar levels. He attributed this to a lack of insulin receptors which prevents glucose from entering cells and being metabolized.
Koçyiğit suggested that polyphenols sourced from olive leaves can increase insulin sensitivity and activity, as well as improving pancreatic responsiveness to assist the body in better metabolizing sugar.
See Also:Olive Oil Health BenefitsThe study confirmed that olive leaves had antimicrobial, antihypertensive and anti-inflammatory properties. It was noted that the anti-hyperglycemic benefits of the leaves were greater in extract form than when brewed as a type of tea.
In 2017, Olive Oil Times reported on a study from Iraq which suggested olive leaf extract held promise as a safe and economical alternative to control diabetes and hyper cholesterol disorders.
The potential of olive leaf polyphenols for reducing the risk of developing Type 2 diabetes also came to light in a 2013 study which suggested that the extract improved insulin sensitivity and pancreatic β‑cell secretory capacity in overweight middle-aged men who were at risk of developing the disease.
Koçyiğit did not respond to a request for comment on the study. However, Roy Taylor, a professor at the diabetes research center at Newcastle University, told Olive Oil Times that olive leaf extract may not play an important role in the treatment or prevention of Type 2 diabetes.
“The study is merely a report of alteration in insulin receptor activity in the test tube,” he said. “As insulin receptor function is normal in Type 2 diabetes (despite much confusing information) this is not supportive of a role in treatment or prevention.”
“However, olive oil can be beneficial provided it is seen as an alternative to animal fats,” he added. “In itself, I know of no sound evidence that it confers any special benefit, and if taken in addition to normal eating it will lead to weight gain.”
For Koçyiğit’s research, mature leaves were gathered from an olive tree in Turkey’s western province of Tekirdag for a year-long cell culture study.
After experimenting with various extraction methods, the research team concluded that using methanol was the most effective method of obtaining a highly concentrated, standardized and stable form of the polyphenol oleuropein. (This was also cited as the best extraction method during an earlier study in Iraq.)
It was noted that further trials on animals and humans were required to ascertain correct dosages for achieving maximum benefits and reducing any risks.
Koçyiğit claimed that discussion with doctors had shown that diabetics favored olive leaf products over other health supplements and suggested that even diabetics who did not consider olive leaf as being beneficial to their Type 2 diabetes believed it delivered other health benefits.
More articles on: diabetes, health, olive oil health
Apr. 14, 2025
Study Shows Potential Health Benefits of Hydroxytyrosol
Hydroxytyrosol, a phenolic compound found in extra virgin olive oil, can lower levels of oxidized LDL cholesterol and may have potential cardiovascular and neuroprotective benefits.
Nov. 4, 2025
Frequent Olive Oil Consumption Linked to Smaller Waistlines, Study Finds
People who consume extra virgin olive oil nearly every day tend to have smaller waistlines, according to a new study examining the dietary habits of more than 16,000 adults.
May. 6, 2025
Italian Health Institute Publishes Mediterranean Diet Guidelines
The 600-page document includes useful health information for physicians, evidence for policymakers and recommendations for the general population.
Jul. 8, 2025
New Study Suggests Olive Oil May Reduce Breast Cancer Risk
New research in Italy suggests that olive oil consumption may be linked to a reduced risk of estrogen and progesterone-negative breast cancer.
Apr. 29, 2025
Study Confirms Olive Oil's Role in Weight Management
A review of 121,119 participants in the Nurses' Health Study found that consuming olive oil is associated with reduced weight gain over time.
Jan. 28, 2025
Mill Wastewater Extract Yields Promising Health Benefits
A dietary supplement made with hydroxytyrosol extracted from olive mill wastewater inhibited the production of inflammatory compounds and showed antibacterial properties.
Oct. 9, 2025
Olive Tree Emerges as Symbol of Interconnected Health and Sustainability
A new review led by Yale researchers highlights the olive tree’s unique role in connecting human, animal, and environmental health — a living model of the “One Health” approach to sustainability.
Oct. 1, 2025
Swiss Psychiatric Hospital Adopts Olive Oil for Patient Health
Extra virgin olive oil is replacing other fats in the PDAG in Switzerland, in a decision driven by scientific evidence.